logo

HDFC Pharma and Healthcare Fund - IDCW Option

Category: Equity: Sectoral-Pharma and Healthcare Launch Date: 04-10-2023
AUM:

₹ 830.67 Cr

Expense Ratio

2.34%

Benchmark

S&P BSE Healthcare

ISIN

INF179KC1HM5

Minimum Investment

100.0

Minimum Topup

100.0

Minimum SIP Amount

0

Fund Manager

Dhruv Muchhal, Nikhil Mathur

Fund Performance 1Y (%) 3Y (%) 5Y (%)
HDFC Pharma and Healthcare Fund - IDCW Option - - -
S&P BSE Healthcare TRI 52.5 14.07 21.99
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%

Overview

NAV
12.588
Last change
-0.01 (-0.1033%)
Fund Size (AUM)
₹ 830.67 Cr
Performance
26.32% (Inception)

Asset Allocation

Equity

Debt

Others

Nav Movement

Investment Objective

The scheme seeks to provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies.

Fund Manager
Dhruv Muchhal, Nikhil Mathur
Riskometer
Very High

Top 10 Holdings

Company Holdings (%)
Sun Pharmaceutical Industries Ltd. 13.51
Cipla Ltd. 7.86
Lupin Ltd. 6.34
Ajanta Pharma Ltd. 4.97
Max Healthcare Institute Ltd. 4.18
Torrent Pharmaceuticals Ltd. 4.11
Krishna Institute of Medical Sciences Ltd 3.93
Gland Pharma Ltd. 3.77
Aurobindo Pharma Ltd. 3.32
Alkem Laboratories Ltd. 3.25

Sector Allocation

Sector Holdings (%)
Healthcare 95.76
Others 1.81
Chemicals 1.44
Services 0.99